BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10178689)

  • 21. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
    Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
    Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
    Somnier FE; Langvad E
    J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on circulating immune complexes. III: Kinetics of the immunoglobulin class of circulating immune complexes in systemic lupus erythematosus.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):201-9. PubMed ID: 2739119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoadsorption therapy (therasorb) in patients with severe lupus erythematosus.
    Graninger M; Schmaldienst S; Derfler K; Graninger WB
    Acta Med Austriaca; 2002; 29(1):26-9. PubMed ID: 11899750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
    Koll RA
    Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy.
    Stummvoll GH; Aringer M; Jansen M; Smolen JS; Derfler K; Graninger WB
    Wien Klin Wochenschr; 2004 Nov; 116(21-22):716-24. PubMed ID: 15628641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of immunoglobulin binding capacities and ligand leakage using eight different protein A affinity chromatography matrices.
    Füglistaller P
    J Immunol Methods; 1989 Nov; 124(2):171-7. PubMed ID: 2600425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
    Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
    J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoadsorption of anti-HLA antibodies on protein A-sepharose columns in hyperimmunized recipients waiting for transplantation].
    Kriaa F; Hiesse C; Farahmand H; Bismuth A; Charpentier B
    Ann Med Interne (Paris); 1994; 145(5):324-7. PubMed ID: 7985941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
    Borghardt EJ; Kirchertz EJ; Marten I; Fenchel K
    Transfus Sci; 1998 Mar; 19 Suppl():5-7. PubMed ID: 10178695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy.
    Gaubitz M; Schneider KM
    Ther Apher Dial; 2003 Apr; 7(2):183-8. PubMed ID: 12918941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ternovoĭ KS; Gandzha IM; Babynina LIa; Volobueva ZV; Sukharenko NV; Dibrova TN; Selezneva TN; Ermekova VM
    Vrach Delo; 1990 Apr; (4):48-50. PubMed ID: 2275166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
    Stummvoll G; Aringer M; Handisurya A; Derfler K
    Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoadsorption (IAS) for systemic lupus erythematosus.
    Stummvoll GH
    Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of immune complexes to IgA-sepharose 4B.
    Moţa G; Dobre MA
    J Immunol Methods; 1984 Dec; 75(2):247-55. PubMed ID: 6520399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of pathogenic autoantibodies by immunoadsorption.
    Hershko AY; Naparstek Y
    Ann N Y Acad Sci; 2005 Jun; 1051():635-46. PubMed ID: 16127004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
    Srdic-Rajic T; Jurisic V; Andrejevic S; Bonaci-Nikolic B; Bowker T; Concas D; Metlas R
    Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tests for circulating immune complexes.
    Wener MH
    Methods Mol Biol; 2014; 1134():47-57. PubMed ID: 24497353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
    Elenitsas R; Abell E; Lee YY; Huang J; Deng JS
    J Dermatol Sci; 1990 May; 1(3):207-15. PubMed ID: 2085508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.